// App-Quantinova.ai

296 : Interrogating metastatic prostate cancer treatment switch decisions.

Researchers

Presenter

  • David Lorente

Principal Investigators

  • Praful Ravi

  • Niven Mehra

  • Carmel Jo Pezaro

  • Aurelius Gabriel Omlin

  • Miguel Miranda

  • Heather Payne

  • Emma Hall

  • Leon W M M Terstappen

  • Maarten J Ijzerman

  • Johann S. De Bono

Medical Centers

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • Kantonsspital St Gallen, St Gallen, Switzerland

  • The Institute of Cancer Research, Sutton, United Kingdom

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • University of Twente, Enschede, Netherlands

  • University of Twente, Enschede, Netherlands

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

Locations

  • United Kingdom

  • Switzerland

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved